logo

The CMPX Stock Puzzle: Unraveling Compass Therapeutics Inc’s Fluctuating Performance

THMO

Compass Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $4.08 on 02/11/25 and a low of $0.76 for the same time frame on 07/05/24.

52-week price history of CMPX Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Compass Therapeutics Inc’s current trading price is -60.54% away from its 52-week high, while its distance from the 52-week low is 110.46%. The stock’s price range during this period has spanned from $0.76 to $4.08. In the Healthcare sector, the Compass Therapeutics Inc’s shares surpassed a trading volume of approximately 7.58 million for the day, which was noticeably higher compared to the average daily volume of 9.1.69 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Compass Therapeutics Inc (CMPX) has experienced a quarterly rise of 12.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 222.64M and boasts a workforce of 35 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2128, with a change in price of -0.2400. Similarly, Compass Therapeutics Inc recorded 1,516,398 in trading volume during the last 100 days, posting a change of -13.41%.

Examining CMPX’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CMPX stands at 0.05. Similarly, the long-term debt-to-equity ratio is also 0.05.

CMPX Stock Stochastic Average

Today, Compass Therapeutics Inc’s raw stochastic average for the past 50 days stands at 8.00%, indicating a decline from the raw stochastic average of the last 20 days, which was 16.48%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 17.93% and 16.36% respectively.

CMPX Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 11.03%. However, over the last six months, the performance has been stronger by -17.01%. The price of CMPX decreased -36.36% over the last 30 days. And in the last five days, it has fallen by -4.73%.

Most Popular